Document: Minimum inhibitory concentration (MIC) breakpoints-2025/4/14

Page: Product-information (QRD) templates - Human-2025/4/14

Document: Quality Review of Documents (QRD) annotated template v11: From for submission of comments to public consultation-2025/4/14

Document: Quality Review of Documents (QRD) annotated template v11: Draft for public consultation-2025/4/14

Document: Quality Review of Documents (QRD) annotated template v11: Draft for public consultation - track changes-2025/4/14

Document: Key information section in package leaflet of centrally authorised medicinal products: Public consultation-2025/4/14

Page: Eligible patients and consumers organisations-2025/4/14

Page: Availability of medicines before and during crises-2025/4/14

Document: Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) to address vulnerabilities in the supply chain of radiopharmaceuticals-2025/4/14

Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2025/4/14